Upstream Biosciences Inc. Announces Appointment of Dr. Geert Cauwenbergh to Its Board of Directors

VANCOUVER, BC--(Marketwire - March 26, 2008) - Upstream Biosciences Inc. (OTCBB: UPBS) today announced the appointment of Geert Cauwenbergh, Ph.D., to its Board of Directors. Dr. Cauwenbergh is the founder of Barrier Therapeutics, Inc., and has been its CEO for the past six years. He has more than 20 years experience in international research, clinical drug development and new product commercialization for both specialty pharmaceuticals and anti-infectives at both pharmaceutical and biotechnology companies, including Johnson & Johnson (J&J) and the Janssen Research Foundation.

Back to news